Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Gross Profit (2022 - 2025)

Cannabis Bioscience International Holdings' Gross Profit history spans 3 years, with the latest figure at $42766.0 for Q4 2025.

  • For Q4 2025, Gross Profit fell 35.64% year-over-year to $42766.0; the TTM value through Nov 2025 reached $84769.0, down 74.12%, while the annual FY2025 figure was $262916.0, 29.36% up from the prior year.
  • Gross Profit for Q4 2025 was $42766.0 at Cannabis Bioscience International Holdings, up from $16057.0 in the prior quarter.
  • Across five years, Gross Profit topped out at $170525.0 in Q3 2024 and bottomed at -$4465.0 in Q1 2025.
  • The 3-year median for Gross Profit is $36588.5 (2025), against an average of $48543.2.
  • The largest annual shift saw Gross Profit skyrocketed 166.44% in 2024 before it tumbled 118.15% in 2025.
  • A 3-year view of Gross Profit shows it stood at $48656.0 in 2023, then skyrocketed by 36.56% to $66445.0 in 2024, then tumbled by 35.64% to $42766.0 in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Gross Profit are $42766.0 (Q4 2025), $16057.0 (Q3 2025), and $30411.0 (Q2 2025).